HbA1c Conversion Chart
Do you currently wear a FreeStyle Libre 2 sensor?
The FreeStyle Libre 2 sensor will be discontinued in the UK end of August 2025.
Speak to your healthcare professional to get your prescription updated to the FreeStyle Libre 2 Plus sensor.
ADC-104300 v1.0
A member of our Customer Service team will then get in touch to help.
GB Mainland: 3 day delivery
Northern Ireland: 3-4 day delivery
(Estimated standard delivery)
All payments are secure and encrypted
Your cart is empty
HbA1c Conversion Chart
Triangle of Diabetes Care
Time in Range
Time in Range is the percentage of readings and time per day you spend within your target glucose range.
The FreeStyle Libre systems* automatically calculate the percentage of time you spend in, above, or below the target range agreed with your Healthcare Professional.1
This example Time in Range report shows a person who spent 75% of their day in target glucose range.
Images are for illustrative purposes only. Not real patent data.
An independent study published in the New England Journal of Medicine shows that FreeStyle Libre 2 users increased their Time in Range by over 2 hours per day:2,**
HbA1c is a great tool for keeping tabs on your glucose levels, but it does have its limitations4
HbA1c reflects your average glucose over the last 2-3 months, but it does not show how often your glucose levels have reached hyper- or hypoglycaemia.4
Time in Range is a complementary measurement for you and your Healthcare Professional to use alongside HbA1c.4,6 And by increasing your Time in Range you’ll see a decrease in your HbA1c.
Every 10% increase in Time in Range = ~0.8% decrease in HbA1c.3
Every hour each day your spend in Range is associated with clinically significant benefits.4
Estimate of A1c for a given Time in Range level based on T1D and T2D studies.3
70% TARGET IS CHOSEN AS IT STRONGLY CORRELATES WITH A1C GOAL OF 7.0%2
You and your Healthcare Professional can get in-depth information about your Time in Range through reports on LibreView₼, our secure, cloud-based diabetes management system.
FreeStyle LibreLink app◊ and FreeStyle Libre 3 app◊◊ users need to create account in LibreView in order for their data automaticallyǁ uploaded to your LibreView.
If you choose to share your LibreView data with your Healthcare Team, they will have access to all your glucose data to help them create a tailored treatment plan for you.
HbA1c Conversion Chart
Triangle of Diabetes Care
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
* FreeStyle Libre systems refers to the FreeStyle Libre 2 and FreeStyle Libre 3 systems
** The data from this study was collected using the FreeStyle Libre 2 system. FreeStyle Libre 3 system has the same features as the FreeStyle Libre 2 system therefore, the study data is applicable to both products.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
◊ The FreeStyle LibreLinkapp is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.
◊◊ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
II The user’s device must have internet connectivity for glucose data to automatically upload to LibreView.
1. The international consensus sets the target in range (3.9-10 mmol/L) for adults with type 1 and type 2 diabetes who are not pregnant, not older, or at risk. Consult with a healthcare professional on individual target glucose range.
2. Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650.
3. Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther. (2019);21(2):81-85.
4. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-16033. Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther. (2019);21(2):81-85.
5. Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. (2019);42(3):400-405.
6. The international consensus report has been endorsed by the ADA, AACE, AADE, EASD, FEND, ISPAD, JDRF, and PES.
The “Yes” link below will take you to a website other than Abbott Laboratories. Links pointing you to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or other links contained on such website. Abbott Laboratories provides these links only as a courtesy and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
FreeStyle.abbott/uk-en is a product specific website only intended for residents of the United Kingdom. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.
Stay connected